Specialized Medical Company (TADAWUL:4019)

Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
18.16
-0.17 (-0.93%)
May 4, 2026, 3:19 PM AST
Market Cap4.54B
Revenue (ttm)1.54B +7.0%
Net Income266.23M +43.7%
EPS1.06 +43.7%
Shares Out250.00M
PE Ratio17.05
Forward PE20.18
Dividend1.12 (6.12%)
Ex-Dividend DateMay 18, 2026
Volume392,800
Average Volume486,853
Open18.31
Previous Close18.33
Day's Range18.08 - 18.32
52-Week Range17.30 - 25.00
Betan/a
RSI46.21
Earnings DateMay 10, 2026

About TADAWUL:4019

Specialized Medical Company owns and operates hospitals, clinics, and medical centers in the Kingdom of Saudi Arabia. The company operates through Medical Services, and Pharmacies and Others segments. It provides diagnostic and therapeutic services for emergency medicine, cardiology, internal and family medicine, and pediatrics; and ancillary services, such as lab histopathology, diagnostic radiology and nuclear medicine, anesthesiology, pharmacy, and physiotherapy rehab. The company also operates surgical units comprising operating room and re... [Read more]

Sector Healthcare
Founded 1994
Employees 3,353
Stock Exchange Saudi Stock Exchange
Ticker Symbol 4019
Full Company Profile

Financial Performance

In 2025, TADAWUL:4019's revenue was 1.54 billion, an increase of 7.00% compared to the previous year's 1.44 billion. Earnings were 266.23 million, an increase of 43.74%.

Financial Statements

News

Specialized Medical Company Earnings Call Transcript: Q4 2025

Strong revenue and profit growth in 2025 driven by acute and outpatient expansion, with a 43.7% rise in net profit and improved margins. Guidance for 2026 is conservative due to ramp-up delays and market competition, but expansion and capital discipline continue.

7 weeks ago - Transcripts

Specialized Medical Company Earnings Call Transcript: Q3 2025

Q3 2025 saw strong revenue and profit growth, driven by a strategic shift to acute and outpatient services, with EBITDA margin rising to 27.3%. Expansion continues with new clinics and hospitals, a SAR 200 million special dividend, and robust guidance for year-end.

6 months ago - Transcripts